Chand-19, Fl flu
Zvinodiwa
Kuongororwa kwakakwana kwekuongororwa kwakakosha kutungamira zvakakodzera anopesana antiviral therapy.
Kunyangwe kugovera zviratidzo zvakafanana, kuwanda-19, flu a uye flu butachiona hunoda kurapwa kwakasiyana kwekutenda kwakasiyana. Fumilenza inogona kurapwa neakakwirisa inhibitors uye yakanyanya kuwanda-19 neRamdesigr / sotrovimab.
Runako mugumisiro mune imwe hutachifunga hazvireve kuti wakasununguka kubva kune vamwe. Zvirwere zve-hutachiona zvinowedzera njodzi dzechirwere chakakomba, muchipatara, rufu nekuda kwesyunergistic mhedzisiro.
Kuongororwa kwakaringana kuburikidza nekuongororwa kwakawanda kwakakosha kutevedzera zvakakodzera antiviral Therapy
Mhinduro Dzedu
Macro & micro-bvunzo'sSars-cov-2, furuwenza a & b antigen yakasanganiswa kuwanikwa.
Kukurumidza kuongororwa kwehutachiona hwakawanda hwekufema, kusanganisira vanochengetedza-cov-2, flu a, uye flhu b neumwe neumwe muenzaniso;
Zvakabatanidzwa zvizere Bvunzo dzinoongororwa nenzvimbo imwechete yekushandisa uye imwe chete sampu inodiwa kusiyanisa pakati peCavid-19, flu a uye flu b;
4 nhanho chete dzekukurumidza Mhedzisiro In chete 15-20 min, inogonesa kuyamwisa clinical sarudzo yekuita.
Multiple Samplum mhando: Nasopharysyaal, Orophaaryngel kana Nasal;
Stoge Tembiricha: 4 -0; c;
Shefu Hupenyu: Mwedzi makumi maviri nemana.
Zviitiko zvakawanda sezvipatara, makiriniki, nzvimbo dzehutano hwenharaunda, pharmacies, nezvimwe.
| SARS-CoV-2 | Flu A | FluB | |
| Kunzwa | 94.36% | 94.92% | 93.79% |
| Chokwadi | 99.81% | 99.81% | 100.00% |
| Kunyatso | 98.31% | 98.59% | 98.73% |
Kutumira Nguva: Jan-18-2024